crossword cybersecurity is a technology commercialisation company focusing exclusively on the cyber security sector. we work with research intensive european university partners to identify promising cyber security intellectual property ("ip") from research that our industry partners tell us meet emerging real-world challenges. our specialist cyber security software engineering team work with our university partners to develop the research concept into a fully fledged commercial product that we bring to market. our first product, rizikon (www.rizikon.io) is a cyber risk analysis and investment prioritisation tool that can help you understand where your biggest vulnerabilities are and how to invest in protecting against them. crossword cybersecurity plc was founded in 2014.
founded in 2011, gogoro is putting energy into things that matter. with a mission to deliver consumer innovations that will improve how the world’s most populated cities distribute and utilize energy, the company is enabling the transformation of megacities into smart cities. gogoro is working toward a better future by putting power in the hands of everyone – to move us all forward, faster.
as a company engaged in real estate investments, irsa is the largest of its kind in the argentine market and the only argentine real estate company listed in the buenos aires stock exchange and the nyse. its main business units are: office rentals, luxury hotels, residential undertakings, land reserves and shopping centers
idt international limited was founded in year 1977 in hong kong. the company started with designs and manufacturing watches and clocks by using newly created lcds and microprocessor technology. each product it manufactured reflects with a sense of excellence, passion and highest pursuits of technology and design. it soon became one of the world’s leading electronic manufacturers. in 1988, idt international limited was listed on the stock exchange of hong kong limited (stock code: 167). the group’s products are marketed to an international customer base served by wholly-owned marketing and distribution subsidiaries around the world.
(CH) RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. It engages in the development and licensing of its portfolio of medicinal products candidates. Its products include aviptadil, for respiratory indications such as sarcoidosis and pulmonary hypertension; and atexakin alfa, for the treatment of diabetic neuropathy. The company was founded in June 2016 and is headquartered in Geneva, Switzerland.